Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome
Background. The optimal duration of antithrombotic therapy (ATT) after patent foramen ovale (PFO) closure remains under debate. This study sought to compare the clinical outcome of patients receiving antithrombotic agents for a short (6 months) versus extended (>6 months) period after the procedu...
Saved in:
Main Authors: | Joelle Kefer, Karlien Carbonez, Sophie Pierard, François-Pierre Mouthuy, Andre Peeters, Cedric Hermans, Catherine Lambert, Christophe DeMeester, Thierry Sluysmans, Agnes Pasquet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Interventional Cardiology |
Online Access: | http://dx.doi.org/10.1155/2022/6559447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patent Foramen Ovale and Closure Technique with the Amplatzer Occluder
by: Bernhard Meier
Published: (2014-01-01) -
Patent Foramen Ovale Closure for Treating Migraine: A Meta-Analysis
by: Yu Zhang, et al.
Published: (2022-01-01) -
Symptomatic Patent Foramen Ovale with Hemidiaphragm Paralysis
by: Hussain Ibrahim, et al.
Published: (2017-01-01) -
Comparison of Patent Foramen Ovale Sizing by Transesophageal Echocardiography and Balloon Sizing in Patients Undergoing Percutaneous Closure
by: Birgitte Carbuhn Larsen, MD, et al.
Published: (2025-01-01) -
A Retrospective Analysis of Self-Limiting Fever following Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure
by: Francesca Galasso, et al.
Published: (2024-01-01)